Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Infusion vs Intermittent IV Bolus of Cefazolin for SSI Prevention in CABG
NCT07658378Phase 4Not yet recruiting
- Sponsor
- Helwan University
- Start
- Jul 2026
- Primary completion
- Sep 2026
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by Helwan University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07658378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658378.